Перепрограммируйте свой мозг с ОКР. Мощные навыки и эффективные методики освобождения от навязчивых мыслей и страхов

Holbrook, A. M., R. Crowther, A. Lotter, C. Cheng, and D. King. 2000. “Meta-Analysis of Benzodiazepine Use in the Treatment of Insomnia.” Canadian Medical Association Journal 162: 225–233.

Koen N., and D. J. Stein. 2011. “Pharmacotherapy of Anxiety Disorders: A Critical Review.” Dialogues in Clinical Neuroscience 13 (4): 423–437.

Koran L. M., and H. B. Simpson. 2013. Guideline Watch (March 2013): Practice Guideline for the Treatment of Patients with Obsessive-Compulsive Disorder. Washington DC: American Psychiatric Association.

Lalive, A. L., U. Rudolph, C. Luscher, and K. R. Tan. 2011. “Is There a Way to Curb Benzodiazepine Addition?” Swiss Medical Weekly 141: 13277.

Marks, I. M., R. P. Swinson, M. Basoglu, et al. 1993. “Alprazolam and Exposure Alone and Combined in Panic Disorder with Agoraphobia: A Controlled Study in London and Toronto.” British Journal of Psychiatry 162: 776–787.

Massart, R., R. Mongeau, and L. Lanfumey. 2012. “Beyond the Monoaminergic Hypothesis: Neuroplasticity and Epigenetic Changes in a Transgenic Mouse Model of Depression.” Philosophical Transactions of the Royal Society B. 367: 2485–2494.

McLean, C. P., L. J. Zandberg, P. E. VanMeter, et al. 2015. “Exposure and Response Prevention Helps Adults with Obsessive Compulsive Disorder Who Do Not Respond to Pharmacological Augmentation Strategies.” Journal of Clinical Psychiatry 76: 1653–1657.

Moore, N., A. Pariente, and B. Begaud. 2015. “Why Are Benzodiazepines Not Yet Controlled Substances?” JAMA Psychiatry 72: 110–111.

Nardi, A. E., R. C. Freire, A. M. Valenca, et al. 2010. “Tapering Clonazepam in Patients with Panic Disorder After at Least 3 Years of Treatment.” Journal of Clinical Psychopharmacology 30: 290–293. National Institute for Health and Care Excellence (NICE). 2005. Obsessive-Compulsive Disorder and Body Dysmorphic Disorder: Treatment. London: National Institute for Health and Care Excellence.

Nischal, A., A. Tripathi, A. Nischel, and J. K. Tivedi. 2012. “Suicide and Antidepressants: What Current Evidence Indicates.” Mens Sana Monographs 10: 33–44.

Offidani, E., Guidi, J., Tomba, E., and Fava, G. A. 2013. “Efficacy and Tolerability of Benzodiazepines Versus Antidepressants in Anxiety Disorders: A Systematic Review and Metaanalysis.” Psychotherapy and Psychosomatics 82: 355–362. doi:10.1159/000353198

Pittman, C., and W. Youngs. 2013. Social Networking and Benzodiazepine Withdrawal: The Realities of Dependence and the Necessity of Support. Paper presented at the 33rd Annual National Conference of the Anxiety and Depression Association of America, La Jolla, California.

Power, K. G., D. W. Jerrom, R. J. Simpson, and M. Mitchell. 1985. “Controlled Study of Withdrawal Symptoms and Rebound Anxiety After Six Week Course of Diazepam for Generalized Anxiety.” British Medical Journal 290: 1246–1248.

Rivas-Vazquez, R. A. 2003. “Benzodiazepines in Contemporary Clinical Practice.” Professional Psychology: Research and Practice 34: 324–328.

Sayyah, M. and F. Rahim. 2018. “Pharmacotherapy for Treatment-Respondent vs. Refractory Obsessive-Compulsive Disorder in Children and Adults: Strategies, Meta-analyses and Clinical Guidelines.” Archives of Psychiatry and Psychotherapy 3: 42–54.

Spiegel, D. A., and T. J. Bruce. 1997. “Benzodiazepines and Exposure-Based Cognitive Behavior Therapies for Panic Disorder: Conclusions from Combined Treatment Trials.” American Journal of Psychiatry 154: 774–781.

Spindelegger, C., R. Lanzenberger, W. Wasdak, et al. 2009. “Influence of Escitalopram Treatment on 5-Ht Receptor Binding in Limbic Region in Patients with Anxiety Disorders.” Molecular Psychiatry 14: 1040–1050.

Storch, E. A., and L. J. Merlo. 2006. “Obsessive-Compulsive Disorder: Strategies for Using CBT and Pharmacotherapy.” Journal of Family Practice 55: 329–333.

Virkuil B., J. F. Brosschot, T. D. Borkovec, and J. F. Thayer. 2009. “Acute Autonomic Effects of Experimental Worry and Cognitive Problem Solving: Why Worry About Worry?” International Journal of Clinical and Health Psychology 9: 439–453.